[Legionellosis in patient treated with infliximab].
Albert
C
C
Vandenbos
F
F
Brocq
O
O
Carles
D
D
Euller-Ziegler
L
L
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D007876:Legionellosis / Q000139:chemically induced* / Q000473:pathology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab